Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 21NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 115Rectal Neoplasms 77Colonic Neoplasms 71Pancreatic Neoplasms 38Stomach Neoplasms 34Esophageal Neoplasms 29Anus Neoplasms 18Adenocarcinoma Of Esophagus 17Carcinoma, Non-Small-Cell Lung 14Carcinoma, Hepatocellular 14Breast Neoplasms 14Biliary Tract Neoplasms 14Neoplasm Metastasis 11Liver Neoplasms 11Lung Neoplasms 10Sarcoma 9Hepatoblastoma 9Gastrointestinal Stromal Tumors 9Ovarian Neoplasms 8Neoplasms 8HIV Infections 8Prostatic Neoplasms 7Gallbladder Neoplasms 7Esophageal Squamous Cell Carcinoma 7Anal Canal Carcinoma 7Small Cell Lung Carcinoma 6Precancerous Conditions 6Neuroblastoma 6Uterine Cervical Neoplasms 5Osteosarcoma 5

Interventions

isatuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Gastrointestinal Hemorrhage × Gastrointestinal × Clear all
NCT03499808 2025-09-09

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

SWOG Cancer Research Network

Phase 2 Completed
43 enrolled 23 charts
GastrointestinalOtherPlasma cell

Lymphadenopathy, Immunoglobulin Light-chain Amyloidosis, Constipation, Diarrhea, Gastrointestinal Hemorrhage, Hepatomegaly, Macroglossia, Nausea, Purpura

Data powered by HemOnc (CC BY 4.0) Colophon âš¡